Mecasermin Pregnancy and Breastfeeding Warnings
Brand names: Increlex
Medically reviewed by Drugs.com. Last updated on May 15, 2023.
Mecasermin Pregnancy Warnings
This drug should be used during pregnancy only if clearly needed.
US FDA pregnancy category: C
Recommendation:
-Women of childbearing potential should have a negative pregnancy test before treatment, and use adequate contraception during treatment.
Animal studies did not show teratogenicity, but did show an increase in fetal death. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Mecasermin Breastfeeding Warnings
Use is not recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
See also
References for pregnancy information
- Product Information. Increlex (mecasermin). Tercica Inc. 2005.
- Cerner Multum, Inc. UK Summary of Product Characteristics.
References for breastfeeding information
- Product Information. Increlex (mecasermin). Tercica Inc. 2005.
- Cerner Multum, Inc. UK Summary of Product Characteristics.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
